May 1, 2026: Judge in Ozempic MDL Issues Two Discovery Orders as Number of NAION Claims Approaches 90 There are 86 claims in the multidistrict litigation about whether Ozempic and other GLP-1s caused some patients to develop NAION
Bariatric surgeons : Patients who dont qualify for surgery or prefer non-surgical options can be referred to you
It was built on years of investment to fully integrate clinical support with Nooms uniquely effective approach to behavior change, culminating in the September 2024 launch of Noom GLP1 Rx Program, our first-ever clinical weight loss plan to include GLP-1 medication (if prescribed), delivered to your door within 7 days, bundled with Nooms GLP-1 Companion app
[41] In a normal person at therapeutic doses, this effect is usually not noticeable, but when respiration is already compromised, it may be evident
The incidence of symptomatic gastroparesis is approximately 14 per 100,000 person-years, but subclinical delayed emptying may be more common
And oftentimes, a patient is switched from a brand name medicine to a generic medicine
